Fundraising FoxJude Gomila — 2022 Investments
5 investments dated 2022 · listed companies and verified rows first · show all
Dashworks builds an AI system designed to answer questions across an organization's internal knowledge and work context.
AI & Machine LearningEnterprise SoftwareFuture of WorkSaaSSan Francisco, US
Prasad Kawthekar(Founder)inPraty Sharma(Founder)in
BoardAshish Toshniwal(Director)in
Co-investorsGaruda VenturesGSF AcceleratorPoint72 VenturesRosecliff VenturesY CombinatorAgrolimen Ventures+11 more
Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors.
AI & Machine LearningBiotechDeep TechHealthtechOxford, GB
Federico Paoletti(CEO & Co-Founder)inAndrea Mambrini(CTO & Co-Founder)in
Co-investorsBeresford VenturesEntrepreneur FirstSelvedge VentureUnruly CapitalCambridge Angels groupNadav Rosenberg+1 more
San Francisco, US
Kazuki Nakayashiki(Executive Officer, Director, Promoter)in
Co-investorsInception Studio CapitalUntapped Capital
Parallelz is building a computing architecture and platform that converts existing native mobile apps into native-web apps without code modifications or SDKs, allowing them to run in a browser without installs or app stores.
Deep TechDeveloper ToolsGaming
Co-investorsMaple VCGlobal Founders CapitalGarage CapitalPlay VenturesTwo Small Fish VenturesInovia Capital+1 more
Triomics builds AI systems for oncology teams that read full patient records and produce structured, auditable outputs for trial matching, visit preparation, and data curation.
AI & Machine LearningHealthtechMedical DevicesNew York City, US
Sarim Khan(Founder)inHrituraj Singh(Founder)inDevtosh Kumar Khare(Director)
BoardSameer Brij Verma(Director)Sajjan Rajpurohit(Director)
Co-investorsBattery VenturesY CombinatorGeneral CatalystLightspeed India PartnersLightspeed Venture PartnersOncology Ventures+2 more
.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.